1. Home
  2. INTT vs QNCX Comparison

INTT vs QNCX Comparison

Compare INTT & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo inTest Corporation

INTT

inTest Corporation

N/A

Current Price

$7.30

Market Cap

94.9M

Sector

Technology

ML Signal

N/A

Logo Quince Therapeutics Inc.

QNCX

Quince Therapeutics Inc.

HOLD

Current Price

$3.65

Market Cap

139.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INTT
QNCX
Founded
1981
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
94.9M
139.2M
IPO Year
1997
2019

Fundamental Metrics

Financial Performance
Metric
INTT
QNCX
Price
$7.30
$3.65
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
$12.00
$8.00
AVG Volume (30 Days)
34.2K
1.2M
Earning Date
11-05-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$117,606,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$9.60
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.24
$0.72
52 Week High
$9.77
$4.55

Technical Indicators

Market Signals
Indicator
INTT
QNCX
Relative Strength Index (RSI) 43.24 59.02
Support Level $7.07 $3.44
Resistance Level $7.50 $4.55
Average True Range (ATR) 0.38 0.38
MACD -0.04 -0.09
Stochastic Oscillator 19.91 28.57

Price Performance

Historical Comparison
INTT
QNCX

About INTT inTest Corporation

inTest Corp is a supplier of test and process solutions for use in manufacturing and testing across a range of markets including automotive, defense/aerospace, industrial, medical, semiconductor and telecommunications. The company manages its business as three operating segments which is also their reporting units that includes Electronic Test, Environmental Technologies and Process Technologies. Electronic Test (which includes semiconductor test equipment, flying probe and in-circuit testers), Environmental Technologies (which includes its thermal test, process and storage products) and Process Technologies (which includes induction heating and video imaging products). The company operates their business and sells its products both domestically and internationally.

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

Share on Social Networks: